Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Hold” by Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received a consensus rating of “Hold” from the eleven research firms that are currently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $11.0625.

A number of research firms recently commented on AVAH. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. UBS Group upped their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a report on Thursday. Zacks Research downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. Barclays upped their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Truist Financial lifted their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th.

Insiders Place Their Bets

In other news, CFO Matthew Buckhalter sold 18,340 shares of the company’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $7.85, for a total transaction of $143,969.00. Following the completion of the transaction, the chief financial officer owned 436,980 shares of the company’s stock, valued at $3,430,293. This represents a 4.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Edwin C. Reisz sold 17,613 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $138,262.05. Following the transaction, the insider owned 1,321,114 shares in the company, valued at approximately $10,370,744.90. The trade was a 1.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 32,857,606 shares of company stock valued at $295,491,307. 7.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of AVAH. Summit Partners L P purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $50,477,000. Vanguard Group Inc. boosted its holdings in Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock valued at $35,850,000 after acquiring an additional 1,041,324 shares during the last quarter. AustralianSuper Pty Ltd purchased a new stake in Aveanna Healthcare during the third quarter valued at about $15,743,000. Connor Clark & Lunn Investment Management Ltd. grew its position in Aveanna Healthcare by 70.1% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,130,912 shares of the company’s stock valued at $10,031,000 after acquiring an additional 466,022 shares during the period. Finally, Algert Global LLC increased its stake in Aveanna Healthcare by 120.1% during the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after acquiring an additional 557,898 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Trading Down 5.5%

Shares of AVAH stock opened at $9.22 on Friday. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The company’s 50-day moving average price is $8.83 and its 200-day moving average price is $7.78. Aveanna Healthcare has a twelve month low of $3.67 and a twelve month high of $10.32. The stock has a market cap of $1.93 billion, a price-to-earnings ratio of 25.61 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, November 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.08. The firm had revenue of $621.94 million for the quarter, compared to analyst estimates of $578.57 million. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%. As a group, equities analysts predict that Aveanna Healthcare will post -0.06 earnings per share for the current year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.